# A Comparative Evaluation of Pharmacokinetics and Immunogenicity.

> **NCT06918587** · PHASE1 · COMPLETED · sponsor: **Kashiv BioSciences, LLC** · enrollment: 180 (actual)

## Conditions studied

- Febrile Neutropenia

## Interventions

- **DEVICE:** TPI-120 with On body injector
- **DRUG:** Fylntera

## Key facts

- **NCT ID:** NCT06918587
- **Lead sponsor:** Kashiv BioSciences, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-05
- **Primary completion:** 2025-05-25
- **Final completion:** 2025-05-25
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06918587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06918587, "A Comparative Evaluation of Pharmacokinetics and Immunogenicity.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06918587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*